Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases

Allergology International

Volumn 60, Issue 1, 2011, Pages 25-35

  Takai, Toshiro ^a   Ikeda, Shigaku ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergen source derived protease; Barrier dysfunction; Endogenous protease inhibitor; Staphylococcus aureus protease; Th2 adjuvant activity

Indexed keywords

ALLERGEN; BACTERIAL ENZYME; CYSTEINE PROTEINASE; DER F 1 ALLERGEN; DER P 1 ALLERGEN; ELAFIN; ELASTASE INHIBITOR; HOUSE DUST ALLERGEN; LYMPHOEPITHELIAL KAZAL TYPE RELATED INHIBITOR; PAPAIN; POLLEN ANTIGEN; PROTEINASE; PROTEINASE INHIBITOR; STEFIN A; THYMIC STROMAL LYMPHOPOIETIN; TRYPSIN; UNCLASSIFIED DRUG; V8 PROTEASE;

ALLERGY; BREATHING MUSCLE; CELL ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME RELEASE; EPIDERMIS; EPITHELIUM CELL; GENETIC ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATORY CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REVIEW; SKIN BARRIER DYSFUNCTION; SKIN DISEASE; SKIN EPITHELIUM; SMOOTH MUSCLE; STAPHYLOCOCCUS AUREUS; TH2 CELL; TIGHT JUNCTION;

EID: 79952797429     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-RAI-0273     Document Type: Review

References (126)

1. Ogawa H, Yoshiike T. A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis. J Dermatol Sci 1993;5:197-204.
2. Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009;129:1892-908.
3. Cork MJ, Robinson DA, Vasilopoulos Y et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006;118:3-21.
4. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008; 121:1337-43.
5. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
6. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009;124(3 Suppl 2):R2-6.
7. Hudson TJ. Skin barrier function and allergic risk. Nat Genet 2006;38:399-400.
8. Brown SJ, McLean WH. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 2009;129: 543-52.
9. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-27.
10. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 2010; 30:269-80.
11. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;120:1233-44;quiz 1245-6.
12. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008;57:1-10.
13. Chapman MD, Wunschmann S, Pomes A. Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 2007;7:363-7.
14. Shakib F, Ghaemmaghami AM, Sewell HF. The molecular basis of allergenicity. Trends Immunol 2008;29:633-42.
15. Shakib F, Schulz O, Sewell H. A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol Today 1998;19:313-6.
16. Reed CE. Inflammatory effect of environmental proteases on airway mucosa. Curr Allergy Asthma Rep 2007;7:368-74.
17. Shen HD, Tam MF, Tang RB, Chou H. Aspergillus and Penicillium allergens: focus on proteases. Curr Allergy Asthma Rep 2007;7:351-6.
18. Gunawan H, Takai T, Ikeda S, Okumura K, Ogawa H. Protease activity of allergenic pollen of cedar, cypress, juniper, birch and ragweed. Allergol Int 2008;57:83-91.
19. Gunawan H, Takai T, Kamijo S et al. Characterization of proteases, proteins, and eicosanoid-like substances in soluble extracts from allergenic pollen grains. Int Arch Allergy Immunol 2008;147:276-88.
20. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008;8:193-204.
21. Takai T. Missions of protease allergens in the epithelium. Int Arch Allergy Immunol 2011;154:3-5.
22. Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002;129:1-18.
23. Dubin G. Extracellular proteases of Staphylococcus spp. Biol Chem 2002;383:1075-86.
24. Nakamura T, Hirasawa Y, Takai T et al. Reduction of skin barrier function by proteolytic activity of a recombinant house dust mite major allergen Der f 1. J Invest Dermatol 2006;126:2719-23.
25. Jeong SK, Kim HJ, Youm JK et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008;128:1930-9.
26. Roelandt T, Heughebaert C, Hachem JP. Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 2008;128:1878-80.
27. Hirasawa Y, Takai T, Nakamura T et al. Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol 2010;130:614-7.
28. Herbert CA, King CM, Ring PC et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol 1995; 12:369-78.
29. Wan H, Winton HL, Soeller C et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999;104:123-33.
30. Wan H, Winton HL, Soeller C et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 2001;31:279-94.
31. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007;12:834-42.
32. Tai HY, Tam MF, Chou H et al. Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy 2006;61: 382-8.
33. Adam E, Hansen KK, Astudillo Fernandez O et al. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 2006;281:6910-23.
34. King C, Brennan S, Thompson PJ, Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 1998;161:3645-51.
35. Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S. Interaction of mite allergens Der p3 and Der p9 with proteaseactivated receptor-2 expressed by lung epithelial cells. J Immunol 2001;167:1014-21.
36. Kato T, Takai T, Fujimura T et al. Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes. Allergy 2009;64:1366-74.
37. Kato T, Takai T, Mitsuishi K, Okumura K, Ogawa H. Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases. J Allergy Clin Immunol 2005;116:169-76.
38. Ogawa T, Takai T, Kato T et al. Upregulation of release of granulocyte-macrophage colony-stimulating factor from keratinocytes stimulated with cysteine protease activity of recombinant major mite allergens, Der f 1 and Der p 1. Int Arch Allergy Immunol 2008;146:27-35.
39. Seto T, Takai T, Ebihara N et al. SLPI prevents cytokine release in mite protease-exposed conjunctival epithelial cells. Biochem Biophys Res Commun 2009;379:681-5.
40. Grunstein MM, Veler H, Shan X, Larson J, Grunstein JS, Chuang S., Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle. J Allergy Clin Immunol 2005;116:94-101.
41. Machado DC, Horton D, Harrop R, Peachell PT, Helm BA. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 1996;26:2972-80.
42. Phillips C, Coward WR, Pritchard DI, Hewitt CR. Basophils express a type 2 cytokine profile on exposure to pro teases from helminths and house dust mites. J Leukoc Biol 2003;73:165-71.
43. Miike S, Kita H. Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J Allergy Clin Immunol 2003;111:704-13.
44. Fujisawa T, Katsumata H, Kato Y. House dust mite extract induces interleukin-9 expression in human eosinophils. Allergol Int 2008;57:141-6.
45. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904-11.
46. Kikuchi Y, Takai T, Kuhara T et al. Crucial commitment of proteolytic activity of a purified recombinant major house dust mite allergen Der p1 to sensitization toward IgE and IgG responses. J Immunol 2006;177:1609-17.
47. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008;9:310-8.
48. Tang H, Cao W, Kasturi SP et al. The T helper type 2 response to cysteine proteases requires dendritic cellbasophil cooperation via ROS-mediated signaling. Nat Immunol 2010;11:608-17.
49. Sakata Y, Arima K, Takai T et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem 2004;279: 5081-7.
50. Sakata Y, Arima K, Takeshita K et al. Characterization of novel squamous cell carcinoma antigen-related molecules in mice. Biochem Biophys Res Commun 2004;324:1340-5.
51. Deraison C, Bonnart C, Lopez F et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007;18:3607-19.
52. Hewitt CR, Brown AP, Hart BJ, Pritchard DI. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J ExpMed 1995;182:1537-44.
53. Hewitt CR, Horton H, Jones RM, Pritchard DI. Heterogeneous proteolytic specificity and activity of the house dust mite proteinase allergen Der p I. Clin Exp Allergy 1997; 27:201-7.
54. Brown A, Farmer K, MacDonald L et al. House dust mite Der p 1 downregulates defenses of the lung by inactivating elastase inhibitors. Am J Respir Cell Mol Biol 2003;29: 381-9.
55. Takai T, Kato T, Sakata Y et al. Recombinant Der p 1 and Der f 1 exhibit cysteine protease activity but no serine protease activity. Biochem Biophys Res Commun 2005; 328:944-52.
56. Ino Y, Ando T, Haida M et al. Characterization of the proteases in the crude mite extract. Int Arch Allergy Appl Immunol 1989;89:321-6.
57. Ando T, Ino Y, Haida M et al. Isolation of cysteine protease in the crude mite extract, Dermatophagoides farinae. Int Arch Allergy Appl Immunol 1991;96:199-205.
58. Ando T, Homma R, Ino Y et al. Trypsin-like protease of mites: purification and characterization of trypsin-like protease from mite faecal extract Dermatophagoides farinae. Relationship between trypsin-like protease and Der f III. Clin Exp Allergy 1993;23:777-84.
59. Stewart GA, Kollinger MR, King CM, Thompson PJ. A comparative study of three serine proteases from Dermatophagoides pteronyssinus and D. farinae. Allergy 1994;49: 553-60.
60. Bagarozzi DA Jr, Pike R, Potempa J, Travis J. Purification and characterization of a novel endopeptidase in ragweed (Ambrosia artemisiifolia) pollen. J Biol Chem 1996;271: 26227-32.
61. Bagarozzi DA Jr, Potempa J, Travis J. Purification and characterization of an arginine-specific peptidase from ragweed (Ambrosia artemisiifolia) pollen. Am J Respir Cell Mol Biol 1998;18:363-9.
62. Noguchi Y, Nagata H, Koganei H et al. Isolation and characterization of aminopeptidase (Jc-peptidase) from Japanese cedar pollen (Cryptomeria japonica). J Agric Food Chem 2002;50:3540-3.
63. Nagata H, Takei T, Kojima R et al. Characteristics of an aminopeptidase from Japanese cedar (Cryptomeria japonica) pollen. J Agric Food Chem 2005;53:5445-8.
64. Ibrahim AR, Kawamoto S, Aki T et al. Molecular cloning and immunochemical characterization of a novel major Japanese cedar pollen allergen belonging to the aspartic protease family. Int Arch Allergy Immunol 2010;152:207-18.
65. Grobe K, Becker WM, Schlaak M, Petersen A. Grass group I allergens (beta-expansins) are novel, papainrelated proteinases. Eur J Biochem 1999;263:33-40.
66. Grobe K, Poppelmann M, Becker WM, Petersen A. Properties of group I allergens from grass pollen and their relation to cathepsin B, a member of the C1 family of cysteine proteinases. Eur J Biochem 2002;269:2083-92.
67. Raftery MJ, Saldanha RG, Geczy CL, Kumar RK. Mass spectrometric analysis of electrophoretically separated allergens and proteases in grass pollen diffusates. Respir Res 2003;4:10.
68. Li LC, Cosgrove DJ. Grass group I pollen allergens (betaexpansins) lack proteinase activity and do not cause wall loosening via proteolysis. Eur J Biochem 2001;268:4217-26.
69. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007;127:2525-32.
70. Kirschner N, Bohner C, Rachow S, Brandner JM. Tight junctions: is there a role in dermatology? Arch Dermatol Res 2010;302:483-93.
71. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008;17:1063-72.
72. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005;6:328-40.
73. Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006;116:1150-8.
74. Strid J, Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 2005;4:531-41.
75. Denda M, Kitamura K, Elias PM, Feingold KR. trans-4-(Aminomethyl) cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol 1997;109:84-90.
76. Hachem JP, Houben E, Crumrine D et al. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006;126:2074-86.
77. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992;98:279-89.
78. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007;28:541-50.
79. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: transducers of proteinasemediated signaling in inflammation and immune response. Endocr Rev 2005;26:1-43.
80. Tan BB, Weald D, Strickland I, Friedmann PS. Doubleblind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347:15-8.
81. Friedmann PS. The role of dust mite antigen sensitization and atopic dermatitis. Clin Exp Allergy 1999;29:869-72.
82. Kramer U, Lemmen C, Bartusel E, Link E, Ring J, Behrendt H. Current eczema in children is related to Der f 1 exposure but not to Der p 1 exposure. Br J Dermatol 2006;154:99-105.
83. Yasueda H, Saito A, Nishioka K, Kutsuwada K, Akiyama K. Measurement of Dermatophagoides mite allergens on bedding and human skin surfaces. Clin Exp Allergy 2003; 33:1654-8.
84. Tovey ER, Chapman MD, Platts-Mills TA. Mite faeces are a major source of house dust allergens. Nature 1981;289: 592-3.
85. Moniaga CS, Egawa G, Kawasaki H et al. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol 2010;176:2385-93.
86. Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977;113:780-2.
87. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
88. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008; 122:62-8.
89. Leyden JJ, Kligman AM. The case for steroid-antibiotic combinations. Br J Dermatol 1977;96:179-87.
90. Gong JQ, Lin L, Lin T et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006;155:680-7.
91. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scaldedskin syndrome targets desmoglein 1. Nat Med 2000;6: 1275-7.
92. Hanakawa Y, Schechter NM, Lin C et al. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 2002; 110:53-60.
93. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005;18:521-40.
94. Vu AT, Baba T, Chen X et al. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol 2010;126:985-93, 993.e1-3.
95. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007;28:248-51.
96. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J ExpMed 2006;203:269-73.
97. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009;183:1427-34.
98. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007;179:1080-7.
99. Kinoshita H, Takai T, Le TA et al. Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. J Allergy Clin Immunol 2009;123:179-86.
100. Reese TA, Liang HE, Tager AM et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007;447:92-6.
101. Trompette A, Divanovic S, Visintin A et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009;457:585-8.
102. Ichikawa S, Takai T, Yashiki T et al. Lipopolysaccharide binding of the mite allergen Der f 2. Genes Cells 2009;14: 1055-65.
103. Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med 2010;16:321-8.
104. Boldogh I, Bacsi A, Choudhury BK et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 2005;115:2169-79.
105. Wang XL, Takai T, Kamijo S, Gunawan H, Ogawa H, Okumura K. NADPH oxidase activity in allergenic pollen grains of different plant species. Biochem Biophys Res Commun 2009;387:430-4.
106. Traidl-Hoffmann C, Mariani V, Hochrein H et al. Pollenassociated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J ExpMed 2005;201:627-36.
107. Kamijo S, Takai T, Kuhara T et al. Cupressaceae pollen grains modulate dendritic cell response and exhibit IgEinducing adjuvant activity in vivo. J Immunol 2009;183: 6087-94.
108. Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991;285:213-9.
109. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996; 377:71-86.
110. Jenko S, Dolenc I, Guncar G, Dobersek A, Podobnik M, Turk D. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo-and exopeptidases. J Mol Biol 2003;326:875-85.
111. Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996;288:442-6.
112. Vasilopoulos Y, Cork MJ, Teare D et al. A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy 2007;62:514-9.
113. Takai T, Kato T, Hatanaka H et al. Modulation of allergenicity of major house dust mite allergens Der f 1 and Der p 1 by interaction with an endogenous ligand. J Immunol 2009;183:7958-65.
114. Takahashi M, Tezuka T, Katunuma N. Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin alpha in skin cornified envelope. FEBS Lett 1994;355:275-8.
115. Takahashi M, Tezuka T, Korant B, Katunuma N. Inhibition of cysteine protease and growth of Staphylococcus aureus V8 and poliovirus by phosphorylated cystatin alpha conjugate of skin. Biofactors 1999;10:339-45.
116. Yuyama N, Davies DE, Akaiwa M et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002; 19:287-96.
117. Mitsuishi K, Nakamura T, Sakata Y et al. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin Exp Allergy 2005;35:1327-33.
118. Kalsheker NA, Deam S, Chambers L, Sreedharan S, Brocklehurst K, Lomas DA. The house dust mite allergen Der p1 catalytically inactivates _1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem Biophys Res Commun 1996;221:59-61.
119. Takai T, Kato T, Ota M et al. Recombinant Der p 1 and Der f 1 with in vitro enzymatic activity to cleave human CD23, CD25 and alpha1-antitrypsin, and in vivo IgEeliciting activity in mice. Int Arch Allergy Immunol 2005; 137:194-200.
120. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000;25:141-2.
121. Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29:175-8.
122. Descargues P, Deraison C, Bonnart C et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005;37:56-65.
123. Briot A, Deraison C, Lacroix M et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J ExpMed 2009;206:1135-47.
124. Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010; 130:2736-42.
125. Hansson L, Backman A, Ny A et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 2002;118:444-9.
126. Bonnart C, Deraison C, Lacroix M et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010;120:871-82.